AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 15 filers reported holding AKARI THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $133,003 | -6.4% | 782,372 | 0.0% | 0.09% | -17.4% |
| Q1 2023 | $142,157 | -61.3% | 782,372 | 0.0% | 0.11% | -63.4% |
| Q4 2022 | $367,637 | -25.4% | 782,372 | 0.0% | 0.30% | -26.4% |
| Q3 2022 | $493,000 | -35.0% | 782,372 | +3.2% | 0.40% | -27.4% |
| Q2 2022 | $758,000 | -16.7% | 758,144 | 0.0% | 0.56% | -7.6% |
| Q1 2022 | $910,000 | -9.1% | 758,144 | +13.7% | 0.60% | -0.8% |
| Q4 2021 | $1,001,000 | +31.5% | 667,085 | +42.8% | 0.61% | +16.2% |
| Q3 2021 | $761,000 | -5.8% | 467,085 | 0.0% | 0.52% | +1.4% |
| Q2 2021 | $808,000 | -26.5% | 467,085 | +12.1% | 0.52% | -36.6% |
| Q1 2021 | $1,100,000 | -99.8% | 416,584 | +6.4% | 0.82% | +23.4% |
| Q4 2020 | $724,430,000 | +106277.4% | 391,584 | 0.0% | 0.66% | +1.7% |
| Q3 2020 | $681,000 | -99.9% | 391,584 | 0.0% | 0.65% | -22.3% |
| Q2 2020 | $853,653,000 | +319620.2% | 391,584 | +112.5% | 0.84% | +201.1% |
| Q1 2020 | $267,000 | -10.1% | 184,258 | +8.6% | 0.28% | +104.4% |
| Q4 2019 | $297,000 | – | 169,663 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 261,192 | $47 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| LPL Financial LLC | 134,453 | $24,430 | 0.00% |
| JPMORGAN CHASE & CO | 237 | $0 | 0.00% |